Compugen Stock Price on October 4, 2024
| CGEN Stock | USD 1.52 0.11 7.80% |
If you're considering investing in Compugen Stock, it is important to understand the factors that can impact its price. As of today, the current price of Compugen stands at 1.52, as last reported on the 27th of November, with the highest price reaching 1.54 and the lowest price hitting 1.37 during the day. Compugen secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of risk over the last 3 months. Compugen exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Compugen's Standard Deviation of 3.49, mean deviation of 2.57, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide.
Compugen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Compugen |
Sharpe Ratio = -0.1118
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CGEN |
Estimated Market Risk
| 3.49 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Compugen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Compugen by adding Compugen to a well-diversified portfolio.
Related Headline
Beam Therapeutics Headline on 4th of October 2024
Acquisition by Walsh Kathleen E of 16532 shares of Beam Ther... by Walsh Kathleen E
Filed transaction by Beam Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Compugen Valuation on October 4, 2024
It is possible to determine the worth of Compugen on a given historical date. On October 4, 2024 Compugen was worth 1.82 at the beginning of the trading date compared to the closed value of 1.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Compugen stock. Still, in general, we apply an absolute valuation method to find Compugen's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Compugen where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Compugen's related companies.
| Open | High | Low | Close | Volume | |
| 1.92 | 1.98 | 1.77 | 1.78 | 365,193 | |
10/04/2024 | 1.82 | 1.84 | 1.78 | 1.83 | 120,940 |
| 1.81 | 1.81 | 1.75 | 1.77 | 164,541 |
| Backtest Compugen | | | Compugen History | | | Compugen Valuation | Previous | Next |
Compugen Trading Date Momentum on October 4, 2024
| On October 07 2024 Compugen was traded for 1.77 at the closing time. The top price for the day was 1.81 and the lowest listed price was 1.75 . The trading volume for the day was 164.5 K. The trading history from October 7, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.28% . The overall trading delta against the current closing price is 5.46% . |
Compugen Fundamentals Correlations and Trends
By evaluating Compugen's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Compugen's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Compugen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Compugen Stock history
Compugen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Compugen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Compugen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Compugen stock prices may prove useful in developing a viable investing in Compugen
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. Compugen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 73 people.
Compugen Stock Technical Analysis
Compugen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Compugen Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Compugen cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Compugen November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Compugen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Compugen shares will generate the highest return on investment. By undertsting and applying Compugen stock market strength indicators, traders can identify Compugen entry and exit signals to maximize returns
Compugen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Compugen's price direction in advance. Along with the technical and fundamental analysis of Compugen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Compugen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | 1.0 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.